Ships within 24 hours Free delivery for orders over 350 EURO Wide selection of high-quality laboratory products Ships within 24 hours Free delivery for orders over 350 EURO Wide selection of high-quality laboratory products Ships within 24 hours Free delivery for orders over 350 EURO Wide selection of high-quality laboratory products Ships within 24 hours Free delivery for orders over 350 EURO Wide selection of high-quality laboratory products Ships within 24 hours Free delivery for orders over 350 EURO Wide selection of high-quality laboratory products Ships within 24 hours Free delivery for orders over 350 EURO Wide selection of high-quality laboratory products Ships within 24 hours Free delivery for orders over 350 EURO

Adalank spray

Sale!


 61.00

Adalank 10 mg spray is a specialized Research Use Only (RUO) chemical reagent intended exclusively for laboratory research on neuromodulatory peptides. This compound is a research analog of Selank—a synthetic heptapeptide described in the scientific literature in the context of neuromodulation, serotonin metabolism, and neurotrophic markers such as BDNF.

Adalank 10 mg spray – chemical reagent for neuromodulatory peptide research

Adalank peptide – Research Use Only (RUO). Chemical reagent intended exclusively for laboratory research. Not intended for human consumption or diagnostic use.

What is Adalank?

Adalank is a research analogue of Selank developed to evaluate neuromodulation, nose-to-brain transport, and changes in neurotrophic and neurochemical markers within broader research peptides workflows. The primary reference point is Selank, a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, widely discussed in Russian experimental literature. Most available data on BDNF expression, serotonin metabolism, and neuropeptide-processing enzymes are based on that scaffold.

Reviews

There are no reviews yet.

Be the first to review “Adalank spray”

Your email address will not be published. Required fields are marked *

INTENDED FOR RESEARCH PURPOSES ONLY!
All of the above properties have been observed in laboratory tests, not on humans, and are for informational purposes only. None of the information contained in the descriptions has been approved by the GIS, GIF, or EFSA. The substance is not a medicine, food product, or dietary supplement, and is therefore not suitable for human consumption. The product qualifies as a chemical reagent/reference material approved for sale in the EU. It can exclusively be used for scientific research. Further information on the product is contained in the chemical safety data sheet, which is available for inspection. The products are only available to institutions or individuals associated with research or laboratory activities.

Data

For Adalank documentation, labs should separate confirmed data from hypothesis-level assumptions. Confirmed elements include trade name, spray format, RUO status, and relationship to Selank analog families. Items that still require batch-level confirmation include the final sequence, potential adamantyl modification, molecular mass of the exact variant, solvent composition, and real post-packaging purity of the ready solution.

Properties of Adalank Spray

In this context, spray is not a marketing detail. It is a technical format that enables evaluation of emitted volume consistency, droplet profile, repeated pump performance, and formulation impact on aerosol deposition in experimental models. This is why many laboratories treat peptide nasal spray characterization as a standalone analytical topic, independent of the peptide’s bioactivity profile.

Intranasal delivery is commonly explored because it may bypass part of the blood-brain barrier constraints. That does not imply identical distribution for all analogues. Outcomes depend on molecular weight, charge, hydrophilicity, stabilizing modifications, carrier viscosity, and surface properties of the solution. For that reason, Adalank spray can be relevant for transport studies, but each project still requires separate formulation validation.

Mechanism of Action

Selank scaffold as the primary reference

Selank is a tuftsin-derived heptapeptide, and rat studies have linked it to changes in monoamine-related processes and neurotrophic signaling. Experimental reports analyzed effects on serotonin and noradrenaline pathways, stress-model behavior, and memory-associated outcomes. This body of work explains why newer analogues with potentially improved stability are compared against Selank-derived benchmarks, including a nootropic peptide stack context.

BDNF and neurotrophic markers

One of the best-known Selank research directions is BDNF expression in the rat hippocampus. A study published in Bulletin of Experimental Biology and Medicine reported that intranasal Selank administration regulated hippocampal BDNF expression in vivo. From a lab perspective, this supports using Selank-derived analogues in projects focused on neurotrophic markers, synaptic plasticity, and neural cell response after peptide exposure.

Serotonergic pathways and neuropeptide metabolism

Another branch of the literature addresses Selank’s impact on serotonin metabolism and enzyme systems involved in neuropeptide turnover. Rat nervous-tissue studies reported changes in carboxypeptidase activity and related peptide-processing elements after Selank exposure. For Adalank, this remains a working hypothesis: if molecular modification affects stability or distribution, labs can compare not only neurotrophic markers but also enzymatic turnover dynamics. For classification and mechanism background, see this nootropic guide.

Impact of molecular modification

Catalog variants labeled as Adalank are commonly described as analogues with higher degradation resistance than baseline Selank. If a given batch confirms additional N-terminus modification or C-terminal amidation, altered proteolysis susceptibility and signal persistence in model systems may be expected. However, this still requires direct confirmation via HPLC stability studies, LC-MS metabolite profiling, and matrix-specific degradation kinetics.

Applications in Scientific Research

Adalank 10 mg spray can be positioned as a research material useful across several experimental areas, with the important reservation that many hypotheses come from Selank literature rather than a broad direct publication base for Adalank itself.

1. BDNF-expression and other neurotrophic-marker models

Because Selank has been studied in the context of hippocampal BDNF in rats, analogues from this family can be investigated for shifts in neurotrophic markers, gene expression, and tissue-level response to peptide exposure.

2. Intranasal models and nose-to-brain transport

Spray formulation supports work on deposition, mucosal retention, transport kinetics, and carrier comparison for low-molecular-weight peptide compounds.

3. Analytical comparisons with baseline Selank

If a Selank reference standard is available, Adalank can be evaluated in direct comparisons of solution stability, degradation profile, HPLC signal, and MS fragmentation patterns.

4. Neuromodulation studies in animal models

Preclinical projects may evaluate behavioral, biochemical, and transcriptomic changes after exposure to a Selank-derived analogue. Conclusions should remain strictly tied to model, species, and exposure conditions.

Conclusion

Adalank 10 mg spray is an RUO chemical reagent best described as a Selank-analogue research formulation. Its laboratory value does not come from non-scientific promises, but from the ability to assess batch quality, solution stability, spray parameters, and interactions in neurochemical and neurotrophic models.

Interpretive discipline is still required. Adalank does not currently have a broad monograph comparable to the best-characterized research peptides. Product narratives should therefore stay anchored to COA, SDS, chromatograms, MS outputs, and a strict separation between direct Adalank data and Selank-based extrapolation.

How should Adalank 10 mg spray be stored in the lab?

Typical practice is refrigerated storage at 2-8C, light protection, and strict tracking of time since first opening. Final handling should follow batch documentation and internal stability protocol.

Key research takeaways

  • Adalank is typically classified as a Selank analogue in a spray-based research formulation.
  • Different suppliers may present structural differences under this catalog name, so each batch should be confirmed by COA, SDS, HPLC, and MS.
  • The strongest literature base still concerns Selank, especially BDNF, serotonin-system studies, and rat exposure models.
  • Spray format introduces an additional technical layer: formulation stability, atomization parameters, and transport evaluation.
  • Documentation should clearly separate direct Adalank evidence from Selank-derived hypotheses.

Referenced Citations

Scientific references

  1. Kolik LG, Nadorova AV, Antipova TA, et al. (2019). Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bull Exp Biol Med. (Rat model; BDNF-related effects in hippocampus and prefrontal cortex.)
  2. Inozemtseva LS, et al. (2008). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Bull Exp Biol Med. (Intranasal exposure and BDNF-expression modulation.)
  3. Andreeva LA, Kozlovskii II, Myasoedov NF. (2009). Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA. Bull Exp Biol Med. (Effects on serotonin metabolism.)
  4. Solov’ev VB, Gengin MT, Sollertinskaia TN, et al. (2012). Effect of selank on the main carboxypeptidases in the rat nervous tissue. Zh Evol Biokhim Fiziol. (Changes in carboxypeptidase activity in nervous tissue.)

Chemical data source

  • PubChem. Selank, CID 11765600. (Reference record for the Selank scaffold; direct “Adalank” query does not currently return a standalone CID in PUG-REST.)